- Antitumor Activity of Oxaliplatin, 5-FU and Paclitaxel Given Alone or in Combination with ZD1839 in Human Gastric Carcinoma Cells in vitro
-
Jang JH, Lee SH, Kang JH, Sun HS, Nishio K, Saijo N, Kuh HJ
- KMID: 1972943
- Cancer Res Treat.
- 2002 Oct;34(5):372-381.
PURPOSE: Oxaliplatin (LOHP), 5-FU, and paclitaxel (PTX) are considered highly active against advanced gastric carcinomas, and the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, ZD1839 is considered as a... -
- CITED
-
- Close
- SHARE
-
- Close
